MedPacto, Inc. (KOSDAQ:235980)

MedPacto Statistics

Total Valuation

MedPacto has a market cap or net worth of KRW 177.20 billion. The enterprise value is 138.23 billion.

Market Cap	177.20B
Enterprise Value	138.23B

Important Dates

The last earnings date was Friday, April 3, 2026.

Earnings Date	Apr 3, 2026
Ex-Dividend Date	n/a

Share Statistics

MedPacto has 34.28 million shares outstanding. The number of shares has increased by 1.70% in one year.

Current Share Class	34.28M
Shares Outstanding	34.28M
Shares Change (YoY)	+1.70%
Shares Change (QoQ)	-0.25%
Owned by Insiders (%)	11.97%
Owned by Institutions (%)	0.32%
Float	25.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	45.45
PB Ratio	3.85
P/TBV Ratio	3.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.79
EV / Sales	35.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.25

Financial Position

The company has a current ratio of 32.86, with a Debt / Equity ratio of 0.04.

Current Ratio	32.86
Quick Ratio	31.08
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-119.72

Financial Efficiency

Return on equity (ROE) is -24.70% and return on invested capital (ROIC) is -16.35%.

Return on Equity (ROE)	-24.70%
Return on Assets (ROA)	-16.04%
Return on Invested Capital (ROIC)	-16.35%
Return on Capital Employed (ROCE)	-29.69%
Weighted Average Cost of Capital (WACC)	6.46%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +88.00% in the last 52 weeks. The beta is 0.40, so MedPacto's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+88.00%
50-Day Moving Average	5,741.70
200-Day Moving Average	5,279.10
Relative Strength Index (RSI)	43.48
Average Volume (20 Days)	647,943

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedPacto had revenue of KRW 3.90 billion and -12.81 billion in losses. Loss per share was -374.00.

Revenue	3.90B
Gross Profit	385.16M
Operating Income	-14.04B
Pretax Income	-12.81B
Net Income	-12.81B
EBITDA	-12.89B
EBIT	-14.04B
Loss Per Share	-374.00

Balance Sheet

The company has 40.70 billion in cash and 1.73 billion in debt, with a net cash position of 38.97 billion or 1,137.07 per share.

Cash & Cash Equivalents	40.70B
Total Debt	1.73B
Net Cash	38.97B
Net Cash Per Share	1,137.07
Equity (Book Value)	45.98B
Book Value Per Share	1,344.96
Working Capital	43.60B

Cash Flow

In the last 12 months, operating cash flow was -13.39 billion and capital expenditures -91.25 million, giving a free cash flow of -13.48 billion.

Operating Cash Flow	-13.39B
Capital Expenditures	-91.25M
Depreciation & Amortization	1.16B
Net Borrowing	-635.09M
Free Cash Flow	-13.48B
FCF Per Share	-393.32

Margins

Gross Margin	9.88%
Operating Margin	-360.24%
Pretax Margin	-328.61%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedPacto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.70%
Shareholder Yield	-1.70%
Earnings Yield	-7.23%
FCF Yield	-7.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.

Last Split Date	May 13, 2020
Split Type	Forward
Split Ratio	2

Scores

MedPacto has an Altman Z-Score of 27.26.

Altman Z-Score	27.26
Piotroski F-Score	n/a